Cerebral small-vessel disease at high altitude: A comparison of patients from plateau and plain

被引:1
|
作者
Shu, Junlong [1 ,2 ]
Fei, Wen [3 ]
Zhang, Jing [1 ]
Li, Fan [1 ]
Hao, Yu [3 ]
Ding, Zhijie [3 ]
Ji, Shiyong [3 ]
Zhao, Weiwei [3 ]
Hu, Yaxiong [3 ]
Sun, Wei [1 ]
Huang, Yining [1 ,2 ]
Zhao, Yuhua [3 ]
Zhang, Wei [1 ,2 ]
机构
[1] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China
[2] Beijing Key Lab Neurovasc Dis Discovery, Beijing, Peoples R China
[3] Peoples Hosp Tibet Autonomous Reg, Dept Neurol, Lhasa, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
cerebral small-vessel disease; white matter hyperintensity; plateau; plain; stroke; lacune of presumed vascular origin; WHITE-MATTER HYPERINTENSITIES; OBSTRUCTIVE SLEEP-APNEA; PARTIAL-PRESSURE; STROKE; OXYGEN; TIBET; MRI;
D O I
10.3389/fneur.2023.1086476
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purposeCerebral small-vessel disease (CSVD) is prevalent worldwide and one of the major causes of stroke and dementia. For patients with CSVD at high altitude, a special environmental status, limited information is known about their clinical phenotype and specific neuroimaging change. We investigated the clinical and neuroimaging features of patients residing at high altitude by comparing with those in the plain, trying to explore the impact of high altitude environment on CSVD. MethodsTwo cohorts of CSVD patients from the Tibet Autonomous Region and Beijing were recruited retrospectively. In addition to the collection of clinical diagnoses, demographic information and traditional vascular risk factors, the presence, location, and severity of lacunes and white matter hyperintensities were assessed by manual counting and using age-related white matter changes (ARWMC) rating scale. Differences between the two groups and influence of long-term residing in the plateau were analyzed. ResultsA total of 169 patients in Tibet (high altitude) and 310 patients in Beijing (low altitude) were enrolled. Fewer patients in high altitude group were found with acute cerebrovascular events and concomitant traditional vascular risk factors. The median (quartiles) ARWMC score was 10 (4, 15) in high altitude group and 6 (3, 12) in low altitude group. Less lacunes were detected in high altitude group [0 (0, 4)] than in low altitude group [2 (0, 5)]. In both groups, most lesions located in the subcortical (especially frontal) and basal ganglia regions. Logistic regressions showed that age, hypertension, family history of stroke, and plateau resident were independently associated with severe white matter hyperintensities, while plateau resident was negatively correlated with lacunes. ConclusionPatients of CSVD residing at high altitude showed more severe WMH but less acute cerebrovascular events and lacunes in neuroimaging, comparing to patients residing at low altitude. Our findings suggest potential biphasic effect of high altitude on the occurrence and progression of CSVD.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Implication of Cerebral Small-Vessel Disease on Perihematomal Edema Progress in Patients With Hypertensive Intracerebral Hemorrhage
    Guo, Wenliang
    Meng, Lanxi
    Lin, Aiyu
    Lin, Yi
    Fu, Ying
    Chen, WanJin
    Li, Shaowu
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 57 (01) : 216 - 224
  • [22] High Circulatory Phosphate Level Is Associated with Cerebral Small-Vessel Diseases
    Chung, Chih-Ping
    Peng, Li-Ning
    Chou, Kun-Hsien
    Liu, Li-Kuo
    Lee, Wei-Ju
    Lin, Ching-Po
    Chen, Liang-Kung
    Wang, Pei-Ning
    TRANSLATIONAL STROKE RESEARCH, 2019, 10 (03) : 265 - 272
  • [23] Cerebral small-vessel disease What lies beyond the early years?
    Potter, Gillian M.
    Roman, Gustavo
    NEUROLOGY, 2011, 76 (08) : 684 - 685
  • [24] Haptoglobin genotype and its relation to asymptomatic cerebral small-vessel disease in type 1 diabetes
    M. I. Eriksson
    A. Syreeni
    N. Sandholm
    E. H. Dahlström
    D. Gordin
    T. Tatlisumak
    J. Putaala
    Per-Henrik Groop
    J. Martola
    L. M. Thorn
    Acta Diabetologica, 2023, 60 : 749 - 756
  • [25] Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
    Wang, Tingting
    Jin, Aoming
    Fu, Ying
    Zhang, Zaiqiang
    Li, Shaowu
    Wang, David
    Wang, Yilong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] Sympathetic Overactivity Based on Heart-Rate Variability in Patients with Obstructive Sleep Apnea and Cerebral Small-Vessel Disease
    Moon, Jangsup
    Choi, Kang Hyun
    Park, Jung Hyun
    Song, Tae-Jin
    Choi, Yun Seo
    Kim, Ju-Hee
    Kim, Hyeon Jin
    Lee, Hyang Woon
    JOURNAL OF CLINICAL NEUROLOGY, 2018, 14 (03): : 310 - 319
  • [27] Haptoglobin genotype and its relation to asymptomatic cerebral small-vessel disease in type 1 diabetes
    Eriksson, M. I.
    Syreeni, A.
    Sandholm, N.
    Dahlstrom, E. H.
    Gordin, D.
    Tatlisumak, T.
    Putaala, J.
    Groop, Per-Henrik
    Martola, J.
    Thorn, L. M.
    ACTA DIABETOLOGICA, 2023, 60 (06) : 749 - 756
  • [28] Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease
    Hassan, A
    Gormley, K
    O'Sullivan, M
    Knight, J
    Sham, P
    Vallance, P
    Bamford, J
    Markus, H
    STROKE, 2004, 35 (03) : 654 - 659
  • [29] Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?
    Grau-Olivares, Marta
    Arboix, Adria
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) : 1201 - 1217
  • [30] Clinical and MRI Features of Cerebral Small-Vessel Disease in Type 1 Diabetes
    Thorn, Lena M.
    Shams, Sara
    Gordin, Daniel
    Liebkind, Ron
    Forsblom, Carol
    Summanen, Paula
    Haegg-Holmberg, Stefanie
    Tatlisumak, Turgut
    Salonen, Oili
    Putaala, Jukka
    Martola, Juha
    Groop, Per-Henrik
    DIABETES CARE, 2019, 42 (02) : 327 - 330